A phase I, dose escalation study to evaluate the safety of second generation malaria vaccines that inhibit the growth of malaria eggs in mosquitoes, preventing transmission of malaria to non-infected persons.
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2015
At a glance
- Drugs Malaria vaccine (Primary)
- Indications Malaria
- Focus Adverse reactions; First in man
- 09 Nov 2015 New trial record